{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:55:41Z","timestamp":1769608541976,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T00:00:00Z","timestamp":1544659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41409-018-0400-5","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T15:39:34Z","timestamp":1544715574000},"page":"1266-1274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A retrospective analysis of haplo-identical HLA-mismatch hematopoietic transplantation without posttransplantation cyclophosphamide for GVHD prophylaxis in patients with adult T-cell leukemia\u2013lymphoma"],"prefix":"10.1038","volume":"54","author":[{"name":"on behalf of ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yoshimitsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atae","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5118-7950","authenticated-orcid":false,"given":"Shigeo","family":"Fuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifusa","family":"Takatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ishitsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Eto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaname","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,13]]},"reference":[{"key":"400_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/sj.bmt.1702731","volume":"27","author":"A Utsunomiya","year":"2001","unstructured":"Utsunomiya A, Miyazaki Y, Takatsuka Y, Hanada S, Uozumi K, Yashiki S, et al. Improved outcome of adult T cell leukemia\/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27:15\u201320. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1702731\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"key":"400_CR2","doi-asserted-by":"publisher","first-page":"e517","DOI":"10.1016\/s1470-2045(14)70202-5","volume":"15","author":"K Ishitsuka","year":"2014","unstructured":"Ishitsuka K, Tamura K. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol. 2014;15:e517\u2013526. \n                    https:\/\/doi.org\/10.1016\/s1470-2045(14)70202-5\n                    \n                  .","journal-title":"Lancet Oncol"},{"key":"400_CR3","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/bmt.2014.143","volume":"49","author":"A Bazarbachi","year":"2014","unstructured":"Bazarbachi A, Cwynarski K, Boumendil A, Finel H, Fields P, Raj K, et al. Outcome of patients with HTLV-1-associated adult T-cell leukemia\/lymphoma after SCT: a retrospective study by the EBMT LWP. Bone Marrow Transplant. 2014;49:1266\u20138. \n                    https:\/\/doi.org\/10.1038\/bmt.2014.143\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"key":"400_CR4","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/bmt.2016.154","volume":"51","author":"EH Phillips","year":"2016","unstructured":"Phillips EH, Hodson A, Hermine O, Bazarbachi A, Cwynarski K. Striving to cure adult T-cell leukaemia\/lymphoma: a role for allogeneic stem cell transplant? Bone Marrow Transplant. 2016;51:1549\u201355. \n                    https:\/\/doi.org\/10.1038\/bmt.2016.154\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"key":"400_CR5","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","volume":"116","author":"M Hishizawa","year":"2010","unstructured":"Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood. 2010;116:1369\u201376. \n                    https:\/\/doi.org\/10.1182\/blood-2009-10-247510\n                    \n                  .","journal-title":"Blood"},{"key":"400_CR6","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/jco.2016.67.8250","volume":"34","author":"S Fuji","year":"2016","unstructured":"Fuji S, Inoue Y, Utsunomiya A, Moriuchi Y, Uchimaru K, Choi I, et al. Pretransplantation anti-CCR4 antibody mogamulizumab against adult T-cell leukemia\/lymphoma is associated with significantly increased risks of severe and corticosteroid-refractory graft-versus-host disease, nonrelapse mortality, and overall mortality. J Clin Oncol. 2016;34:3426\u201333. \n                    https:\/\/doi.org\/10.1200\/jco.2016.67.8250\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"400_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1200\/jco.2016.67.8250","volume":"53","author":"Y Inoue","year":"2018","unstructured":"Inoue Y, Fuji S, Tanosaki R, Inamoto Y, Tanaka T, Ito A. et al. Prognostic importance of pretransplant disease status for posttransplant outcomes in patients with adult T cell leukemia\/lymphoma. Bone Marrow Transplant. 2018;53:1105\u201315. \n                    https:\/\/doi.org\/10.1200\/jco.2016.67.8250\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"400_CR8","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.bbmt.2017.11.005","volume":"24","author":"Makoto Yoshimitsu","year":"2018","unstructured":"Yoshimitsu M, Tanosaki R, Kato K, Ishida T, Choi I, Takatsuka Y et al. Risk Assessment in Adult T Cell Leukemia\/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018; 24(4): 832-839. e-pub ahead of print 2017\/11\/21; \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2017.11.005\n                    \n                  .","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"400_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/bmt.2015.265","volume":"51","author":"S Fuji","year":"2016","unstructured":"Fuji S, Fujiwara H, Nakano N, Wake A, Inoue Y, Fukuda T, et al. Early application of related SCT might improve clinical outcome in adult T-cell leukemia\/lymphoma. Bone Marrow Transplant. 2016;51:205\u201311. \n                    https:\/\/doi.org\/10.1038\/bmt.2015.265\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"400_CR10","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.bbmt.2014.08.012","volume":"20","author":"Koji Kato","year":"2014","unstructured":"Kato K, Choi I, Wake A, Uike N, Taniguchi S, Moriuchi Y et al. Treatment of patients with adult T cell leukemia\/lymphoma with cord blood transplantation: a Japanese nationwide retrospective survey. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2014; 20(12): 1968-1974. e-pub ahead of print 2014\/08\/31; \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2014.08.012\n                    \n                  .","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"400_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O\u2019Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2008;14:641\u201350. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2008.03.005\n                    \n                  .","journal-title":"Biol Blood Marrow Transplant"},{"key":"400_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","volume":"8","author":"PV O\u2019Donnell","year":"2002","unstructured":"O\u2019Donnell PV, Luznik L, Jones RJ, Vogelsang GB, Leffell MS, Phelps M, et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2002;8:377\u201386.","journal-title":"Biol Blood Marrow Transplant"},{"key":"400_CR13","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1200\/jco.2014.60.4777","volume":"33","author":"YL Kasamon","year":"2015","unstructured":"Kasamon YL, Bolanos-Meade J, Prince GT, Tsai HL, McCurdy SR, Kanakry JA, et al. Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults. J Clin Oncol. 2015;33:3152\u201361. \n                    https:\/\/doi.org\/10.1200\/jco.2014.60.4777\n                    \n                  .","journal-title":"J Clin Oncol"},{"issue":"11","key":"400_CR14","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.bbmt.2017.07.003","volume":"23","author":"Nilanjan Ghosh","year":"2017","unstructured":"Ghosh N, Ye X, Tsai HL, Bolanos-Meade J, Fuchs EJ, Luznik L, et al. Allogeneic blood or marrow transplantation with post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis in multiple myeloma. Biol Blood Marrow Transplant. 2017;23:1903\u20139. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2017.07.003","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"400_CR15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/sj.bmt.1704692","volume":"34","author":"K Obama","year":"2004","unstructured":"Obama K, Utsunomiya A, Takatsuka Y, Takemoto Y. Reduced-intensity non-T-cell depleted HLA-haploidentical stem cell transplantation for older patients based on the concept of feto-maternal tolerance. Bone Marrow Transplant. 2004;34:897\u20139. \n                    https:\/\/doi.org\/10.1038\/sj.bmt.1704692\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"key":"400_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12185-008-0042-2","volume":"87","author":"H Fujiwara","year":"2008","unstructured":"Fujiwara H, Ozaki A, Yoshimitsu M, Hamada H, Masamoto I, Matsushita K, et al. Allogeneic stem cell transplantation for refractory adult T-cell leukemia using a non-T-cell-depleted HLA-incompatible family donor graft, with reference to the grown-up child donor to parent recipient setting: report of a pilot study. Int J Hematol. 2008;87:319\u201326. \n                    https:\/\/doi.org\/10.1007\/s12185-008-0042-2\n                    \n                  .","journal-title":"Int J Hematol"},{"key":"400_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2009;15:367\u20139. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2008.12.497\n                    \n                  .","journal-title":"Biol Blood Marrow Transplant"},{"key":"400_CR18","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant. 2009;15:1628\u201333. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2009.07.004\n                    \n                  .","journal-title":"Biol Blood Marrow Transplant"},{"issue":"S1","key":"400_CR19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/bmt.2012.282","volume":"48","author":"Simona Iacobelli","year":"2013","unstructured":"Iacobelli S. Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation. Bone marrow transplantation 2013; 48 Suppl 1: S1-37. e-pub ahead of print 2013\/03\/15; \n                    https:\/\/doi.org\/10.1038\/bmt.2012.282\n                    \n                  .","journal-title":"Bone Marrow Transplantation"},{"issue":"3","key":"400_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2012","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone marrow transplantation 2013; 48(3): 452-458. e-pub ahead of print 2012\/12\/05; \n                    https:\/\/doi.org\/10.1038\/bmt.2012.244\n                    \n                  .","journal-title":"Bone Marrow Transplantation"},{"key":"400_CR21","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1182\/blood-2012-03-414490","volume":"120","author":"T Ishida","year":"2012","unstructured":"Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Taniguchi S, et al. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study. Blood. 2012;120:1734\u201341. \n                    https:\/\/doi.org\/10.1182\/blood-2012-03-414490\n                    \n                  .","journal-title":"Blood"},{"key":"400_CR22","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.bbmt.2015.04.012","volume":"21","author":"K Ikegame","year":"2015","unstructured":"Ikegame K, Yoshida T, Yoshihara S, Daimon T, Shimizu H, Maeda Y, et al. Unmanipulated haploidentical reduced-intensity stem cell transplantation using fludarabine, busulfan, low-dose antithymocyte globulin, and steroids for patients in non-complete remission or at high risk of relapse: a prospective multicenter phase I\/II study in Japan. Biol Blood Marrow Transplant. 2015;21:1495\u2013505. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2015.04.012\n                    \n                  .","journal-title":"Biol Blood Marrow Transplant"},{"key":"400_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-017-0082-4","author":"S Fuji","year":"2018","unstructured":"Fuji S, Kurosawa S, Inamoto Y, Murata T, Utsunomiya A, Uchimaru K, et al. Role of up-front allogeneic hematopoietic stem cell transplantation for patients with aggressive adult T-cell leukemia-lymphoma: a decision analysis. Bone Marrow Transplant. 2018. \n                    https:\/\/doi.org\/10.1038\/s41409-017-0082-4\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"400_CR24","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1111\/cas.13398","volume":"108","author":"Kisato Nosaka","year":"2017","unstructured":"Nosaka K, Iwanaga M, Imaizumi Y, Ishitsuka K, Ishizawa K, Ishida Y et al. Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-1: a nationwide survey. Cancer Sci. 2017;108:2478-86. \n                    https:\/\/doi.org\/10.1111\/cas.13398","journal-title":"Cancer Science"},{"key":"400_CR25","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1080\/10428194.2016.1266624","volume":"58","author":"Y Arai","year":"2017","unstructured":"Arai Y, Jo T, Matsui H, Kondo T, Takaori-Kondo A. Efficacy of antithymocyte globulin for allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis. Leuk Lymph. 2017;58:1840\u20138. \n                    https:\/\/doi.org\/10.1080\/10428194.2016.1266624\n                    \n                  .","journal-title":"Leuk Lymph"},{"key":"400_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/s1470-2045(15)00462-3","volume":"17","author":"I Walker","year":"2016","unstructured":"Walker I, Panzarella T, Couban S, Couture F, Devins G, Elemary M, et al. Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial. Lancet Oncol. 2016;17:164\u201373. \n                    https:\/\/doi.org\/10.1016\/s1470-2045(15)00462-3\n                    \n                  .","journal-title":"Lancet Oncol"},{"issue":"10","key":"400_CR27","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1182\/blood-2004-11-4193","volume":"105","author":"J. Okamura","year":"2005","unstructured":"Okamura J, Utsunomiya A, Tanosaki R, Uike N, Sonoda S, Kannagi M et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma. Blood 2005; 105(10): 4143-4145. e-pub ahead of print 2005\/01\/25; \n                    https:\/\/doi.org\/10.1182\/blood-2004-11-4193\n                    \n                  .","journal-title":"Blood"},{"key":"400_CR28","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.bbmt.2008.08.014","volume":"14","author":"LM Burroughs","year":"2008","unstructured":"Burroughs LM, O\u2019Donnell PV, Sandmaier BM, Storer BE, Luznik L, Symons HJ, et al. Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma. Biol Blood Marrow Transplant. 2008;14:1279\u201387. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2008.08.014\n                    \n                  .","journal-title":"Biol Blood Marrow Transplant"},{"issue":"26","key":"400_CR29","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1200\/JCO.2017.72.8428","volume":"35","author":"Asad Bashey","year":"2017","unstructured":"Bashey A, Zhang MJ, McCurdy SR, St Martin A, Argall T, Anasetti C, et al. Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide. J Clin Oncol. 2017;35:3002\u20139. \n                    https:\/\/doi.org\/10.1200\/jco.2017.72.8428\n                    \n                  .","journal-title":"Journal of Clinical Oncology"},{"key":"400_CR30","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.bbmt.2016.11.008","volume":"23","author":"SA Srour","year":"2017","unstructured":"Srour SA, Milton DR, Bashey A, Karduss-Urueta A, Al Malki MM, Romee R, et al. Haploidentical transplantation with post-transplantation cyclophosphamide for high-risk acute lymphoblastic leukemia. Biol Blood Marrow Transplant. 2017;23:318\u201324. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2016.11.008\n                    \n                  .","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0400-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0400-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0400-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:13:37Z","timestamp":1684617217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0400-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,13]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["400"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0400-5","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,13]]},"assertion":[{"value":"9 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}